SPRY: ARS Pharmaceuticals, Inc. Stock

by  •  • Comments Off on SPRY: ARS Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,316.90
Enterprise Value ($M) 1,346.42
Book Value ($M) 228.97
Book Value / Share 2.33
Price / Book 5.75
NCAV ($M) 205.52
NCAV / Share 2.09
Price / NCAV 6.41

Profitability (mra)
Return on Invested Capital (ROIC) -0.05
Return on Assets (ROA) -0.07
Return on Equity (ROE) -0.07

Liquidity (mrq)
Quick Ratio 10.74
Current Ratio 11.00

Balance Sheet (mrq) ($M)
Current Assets 303.86
Assets 327.32
Liabilities 98.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 89.15
Operating Income -3.08
Net Income 8.00

Cash Flow Statement (mra) ($M)
Cash From Operations 13.55
Cash from Investing -106.10
Cash from Financing 72.40

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-24 13D/A Deerfield Mgmt III, L.P. 10.72
06-17 13D/A Pratik Shah Living Trust dated June 15, 2011 5.40 -20.34

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-12-06 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANS
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-05 248,010 1,107,398 22.40
2025-06-04 215,546 752,088 28.66
2025-06-03 256,853 1,044,352 24.59
2025-06-02 265,819 841,764 31.58

(click for more detail)

Similar Companies
SIGA – SIGA Technologies, Inc. SKYE – Skye Bioscience, Inc.
SMMT – Summit Therapeutics Inc. STRO – Sutro Biopharma, Inc.
SUPN – Supernus Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io